Kymera Therapeutics (KYMR)Director sold ~$123K

~$123K

Approx. value · 2,500 sh @ $49.00

Traded

Dec 2, 2024

Filed

Dec 3, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Dec 2, 2024 · this disclosureInsiderDirector sold ~$123K of KYMR shares in the open market

What came next

1. Jan 6, 2025InsiderOfficer sold ~$131K of KYMR shares in the open market
2. Mar 3, 2025Insider · 4 peopleInsiders: 8 sales (~$499K)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Kymera Therapeutics

For Kymera Therapeutics, OQRO holds 6 insider filings (SEC Form 4 or Form 144) and 6 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its KYMR page.

Other recent filings by Pamela Esposito, Director

• SEC Form 4 at Kymera Therapeutics (KYMR)Jun 3, 2025

The full history of Pamela Esposito, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Kymera Therapeutics

• SEC Form 4Oct 1, 2026
• SEC Form 4Oct 1, 2026
• SEC Form 4Oct 1, 2026
• SEC Form 4Oct 1, 2026
• SEC Form 4Oct 1, 2026
• SEC Form 4Oct 1, 2026

Everything OQRO holds on this company is on its KYMR page.